- Wineinger NE, Zhang Y, Topol EJ. Trends in prices of popular brand-name prescription drugs in the United States. JAMA Netw Open. 2019;2(5):e194791. doi:https://doi.org/10.1001/jamanetworkopen.2019.4791.
- Tolbert J, Orgera K, Singer N, Damico A. Key facts about the uninsured population. The Henry J. Kaiser Family Foundation. December 2019. https://files.kff.org/attachment//fact-sheet-key-facts-about-the-uninsured-population. Accessed August 1, 2021.
- Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. doi:https://doi.org/10.2147/RMHP.S19801.
- Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–530. doi:https://doi.org/10.1097/01.mlr.0000163641.86870.af.
- Darnell JS. Free clinics in the United States: a nationwide survey. Arch Intern Med. 2010;170(11):946–953. doi:https://doi.org/10.1001/archinternmed.2010.107.
- Gao L, Joseph J, Santoro-Levy M, Multz AS, Gotlieb VK. Utilization of pharmaceutical patient and prescription assistance programs via a pharmacy department patient assistance program for indigent cancer patients. Hosp Pharm. 2016;51(7):572–576. doi:https://doi.org/10.1310/hpj5107-572.
- Sarrafizadeh M, Waite NM, Hobson EH, Migden H. Pharmacist-facilitated enrollment in medication assistance programs in a private ambulatory care clinic. Am J Health Syst Pharm. 2004;61(17):1816–1820. doi:https://doi.org/10.1093/ajhp/61.17.1816.
- Clay P, Vaught E, Glaros A, Mangum S, Hansen D, Lindsey C. Costs to physician offices of providing medications to medically indigent patients via pharmaceutical manufacturer prescription assistance programs. J Manag Care Pharm. 2007;13(6):506–514. doi:https://doi.org/10.18553/jmcp.2007.13.6.506.
- Carroll NV. Pharmaceutical patient assistance programs: don't look a gift horse in the mouth or there's no such thing as a free lunch. J Manag Care Pharm. 2007;13(7):614–616. doi:https://doi.org/10.18553/jmcp.2007.13.7.614.
- Duke KS, Raube K, Lipton HL. Patient-assistance programs: assessment of and use by safety-net clinics. Am J Health Syst Pharm. 2005;62(7):726–731. doi:https://doi.org/10.1093/ajhp/62.7.726.
- Trompeter JM, Havrda DE. Impact of obtaining medications from pharmaceutical company assistance programs on therapeutic goals. Ann Pharmacother. 2009;43(3):469–477. doi:https://doi.org/10.1345/aph.1L420.
Cost savings analysis of prescription assistance programs at a student-run free clinic
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.